Measuring lipoprotein(a) for cardiovascular disease prevention - in whom and when?

Keyphrases

• Lipoproteins 100%
• Cardiovascular Prevention 100%
• Comorbidity 28%
• Cardiovascular Disease 14%
• Risk Stratification 14%
• Aortic Valve Stenosis 14%
• Risk Prediction 14%
• Phase II Trial 14%
• Adult Individuals 14%
• Atherosclerotic Cardiovascular Disease (ASCVD) 14%
• International Guidelines 14%
• Causal Risk Factors 14%
• Guideline Recommendations 14%
• Lifetime Measurement 14%

Medicine and Dentistry

• Lipoprotein 100%
• Cardiovascular Disease Prevention 100%
• Cardiovascular System 14%
• Risk Stratification 14%
• Cardiovascular Disease 14%
• Aortic Valve Stenosis 14%
• Lifespan 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Cardiovascular Disease 100%
• Lipoprotein A 100%
• Comorbidity 28%
• Coronary Artery Atherosclerosis 14%
• Aortic Valve Stenosis 14%